Clonidine is used for treating high blood pressure, chest pain, and heart failure. It was first introduced by Lavipharm Sa in its drug Catapres-Tts-1 on Oct 10, 1984. Other drugs containing Clonidine are Catapres-Tts-2, Nexiclon Xr, Clonidine, Catapres-Tts-3. 7 different companies have introduced drugs containing Clonidine.

Clonidine Patents

Given below is the list of patents protecting Clonidine, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Nexiclon Xr	US8623409	Clonidine formulation	Sep 08, 2031	Athena
Nexiclon Xr	US8337890	Modified release formulations containing drug-ion exchange resin complexes	Apr 17, 2027	Athena

Add above patents to watchlist

Clonidine's Family Patents

Full family tree

Clonidine Generic API Manufacturers

Several generic applications have been filed for Clonidine. The first generic version for Clonidine was by Difgen Pharmaceuticals Llc and was approved on Aug 18, 2009. And the latest generic version is by Actavis Laboratories Ut Inc and was approved on May 6, 2014.

Given below is the list of companies who have filed for Clonidine generic, along with the locations of their manufacturing plants worldwide.